National Project Implementation Plan - NVBDCP
National Project Implementation Plan - NVBDCP
National Project Implementation Plan - NVBDCP
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
The activity schedule for quality assurance for malaria and Kala-azar will be<br />
the same. This is summarized below:<br />
Result Indicator Activity<br />
Good<br />
quality of<br />
drugs and<br />
commodeties<br />
ensured<br />
% of<br />
districts<br />
from where<br />
samples<br />
were<br />
tested<br />
Requirements for all<br />
items consolidated<br />
Quality specification set<br />
for kits , drugs and<br />
commodities<br />
Time<br />
Schedule<br />
To be<br />
discussed<br />
April 08<br />
Responsibility<br />
<strong>NVBDCP</strong>/NIMR<br />
/RMRI<br />
<strong>NVBDCP</strong>/ SPO<br />
% of<br />
samples<br />
passed<br />
Procurement plan made<br />
and submitted to UNOPS<br />
Distribution plan made<br />
and submitted to states<br />
and districts<br />
May 08<br />
June 08<br />
-do-<br />
-do-<br />
Inspection agency hired<br />
through UNOPS/ICMR<br />
Institution<br />
Aug 08<br />
<strong>NVBDCP</strong>/NIMR<br />
/RMRI<br />
Samples collected for<br />
testing from field as well<br />
as at point of<br />
procurement at central<br />
level<br />
Sept 08<br />
-do-<br />
Results communicated to<br />
the districts and<br />
supplying agencies.<br />
Quarterly<br />
Continuous<br />
-do-<br />
7.1.1.4 Operational research and technology assessment<br />
The program will identify priorities for research. Some of the areas<br />
identified are:<br />
Validation of rapid diagnostic test for Pv and Pf;<br />
Operational experience with ‘rk 39’;[ presently used in the programme]<br />
Trials of alternative ACT; and fixed dose combination<br />
Monitoring of drug resistance – ACT, Miltefosine;<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
Monitoring of vector susceptibility test;<br />
Evaluation of different delivery models in public private partnerships<br />
including private providers for curative services in malaria control and<br />
Kala-azar elimination;<br />
Cost effective active case detection for malaria and kala-azar;<br />
Treatment of PKDL;<br />
Research on shorter duration treatment of kala-azar with combination<br />
drugs;<br />
Increasing the access to diagnostic and treatment services to the poor<br />
and people living in inaccessible areas;<br />
The trial of compression sprayers in improving IRS with DDT 70%wdp;<br />
58